Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Antimicrobial susceptibility in Neisseria gonorrhoeae isolates from five sentinel surveillance sites in Zimbabwe, 2015-2016.

Latif AS, Gwanzura L, Machiha A, Ndowa F, Tarupiwa A, Gudza-Mugabe M, Shukusho FD, Chakanyuka Musanhu C, Wi T, Unemo M.

Sex Transm Infect. 2017 May 5. pii: sextrans-2016-053090. doi: 10.1136/sextrans-2016-053090. [Epub ahead of print]

PMID:
28476914
2.

Estimating prevalence trends in adult gonorrhoea and syphilis in low- and middle-income countries with the Spectrum-STI model: results for Zimbabwe and Morocco from 1995 to 2016.

Korenromp EL, Mahiané G, Rowley J, Nagelkerke N, Abu-Raddad L, Ndowa F, El-Kettani A, El-Rhilani H, Mayaud P, Chico RM, Pretorius C, Hecht K, Wi T.

Sex Transm Infect. 2017 Mar 21. pii: sextrans-2016-052953. doi: 10.1136/sextrans-2016-052953. [Epub ahead of print]

3.

Gonococcal antimicrobial resistance: challenges for public health control.

Ndowa FJ, Ison CA, Cole MJ, Lusti-Narasimhan M.

Sex Transm Infect. 2013 Dec;89 Suppl 4:iv3-4. doi: 10.1136/sextrans-2013-051395. No abstract available.

PMID:
24243877
4.

Gonococcal antimicrobial resistance: perspectives from the African region.

Ndowa FJ, Francis JM, Machiha A, Faye-Kette H, Fonkoua MC.

Sex Transm Infect. 2013 Dec;89 Suppl 4:iv11-5. doi: 10.1136/sextrans-2012-050907. Review.

PMID:
24243873
5.

Gonococcal antimicrobial resistance: the implications for public health control.

Ndowa FJ, Ison CA, Lusti-Narasimhan M.

Sex Transm Infect. 2013 Dec;89 Suppl 4:iv1-2. doi: 10.1136/sextrans-2013-051394. No abstract available.

PMID:
24243872
6.

WHO guidelines for HIV/STI prevention and care among MSM and transgender people: implications for policy and practice.

Cohen J, Lo YR, Caceres CF, Klausner JD; WHO guideline working group.

Sex Transm Infect. 2013 Nov;89(7):536-8. doi: 10.1136/sextrans-2013-051121. No abstract available.

PMID:
24123866
7.

Antimicrobial resistance monitoring in Neisseria gonorrhoeae and strategic use of funds from the Global Fund to set up a systematic Moroccan gonococcal antimicrobial surveillance programme.

Hançali A, Ndowa F, Bellaji B, Bennani A, Kettani A, Charof R, El Aouad R.

Sex Transm Infect. 2013 Dec;89 Suppl 4:iv24-7. doi: 10.1136/sextrans-2013-051166. Epub 2013 Sep 13.

PMID:
24037141
8.

The threat of untreatable gonorrhoea: implications and consequences for reproductive and sexual morbidity.

Ndowa F, Lusti-Narasimhan M.

Reprod Health Matters. 2012 Dec;20(40):76-82. doi: 10.1016/S0968-8080(12)40653-X.

PMID:
23245412
9.
10.

Importance of sexually transmitted infections in funding for HIV within proposals to the Global Fund.

Lusti-Narasimhan M, Ndowa F, Pires SS.

Sex Transm Infect. 2011 Dec;87 Suppl 2:ii19-22. doi: 10.1136/sextrans-2011-050183. No abstract available.

11.

Periodic presumptive treatment of curable sexually transmitted infections among sex workers: a systematic review.

Steen R, Chersich M, Gerbase A, Neilsen G, Wendland A, Ndowa F, Akl EA, Lo YR, de Vlas SJ.

AIDS. 2012 Feb 20;26(4):437-45. doi: 10.1097/QAD.0b013e32834ed991. Review.

PMID:
22095197
12.

The WHO policy package to combat antimicrobial resistance.

Leung E, Weil DE, Raviglione M, Nakatani H; World Health Organization World Health Day Antimicrobial Resistance Technical Working Group.

Bull World Health Organ. 2011 May 1;89(5):390-2. doi: 10.2471/BLT.11.088435. No abstract available.

13.

Sexually transmitted diseases treatment guidelines, 2010.

Workowski KA, Berman S; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2010 Dec 17;59(RR-12):1-110. Erratum in: MMWR Recomm Rep. 2011 Jan 14;60(1):18. Dosage error in article text.

14.

What have we learned from sexually transmitted infection research in sub-Saharan Africa?

Mabey D, Ndowa F, Latif A.

Sex Transm Infect. 2010 Dec;86(7):488-92. doi: 10.1136/sti.2009.041632. Review.

PMID:
21113067
15.

Genital ulcer disease treatment policies and access to acyclovir in eight sub-Saharan African countries.

Corbell C, Stergachis A, Ndowa F, Ndase P, Barnes L, Celum C.

Sex Transm Dis. 2010 Aug;37(8):488-93. doi: 10.1097/OLQ.0b013e3181e212e5.

PMID:
20539260
16.

Control of sexually transmitted infections and prevention of HIV transmission: mending a fractured paradigm.

Steen R, Wi TE, Kamali A, Ndowa F.

Bull World Health Organ. 2009 Nov;87(11):858-65.

17.

Using mathematical modelling to estimate the impact of periodic presumptive treatment on the transmission of sexually transmitted infections and HIV among female sex workers.

Vickerman P, Ndowa F, O'Farrell N, Steen R, Alary M, Delany-Moretlwe S.

Sex Transm Infect. 2010 Jun;86(3):163-8. doi: 10.1136/sti.2008.034678. Epub 2009 Oct 22.

PMID:
19854700
18.

Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae.

Tapsall JW, Ndowa F, Lewis DA, Unemo M.

Expert Rev Anti Infect Ther. 2009 Sep;7(7):821-34. doi: 10.1586/eri.09.63. Review.

PMID:
19735224
19.

Modelling the cost per ulcer treated of incorporating episodic treatment for HSV-2 into the syndromic algorithm for genital ulcer disease.

Vickerman P, Ndowa F, Mayaud P.

Sex Transm Infect. 2008 Jun;84(3):243-8. doi: 10.1136/sti.2007.027136. Epub 2008 Apr 2.

PMID:
18385226
20.

WHO global strategy for the prevention and control of sexually transmitted infections: time for action.

Lewis DA, Latif AS, Ndowa F.

Sex Transm Infect. 2007 Dec;83(7):508-9. No abstract available.

Supplemental Content

Loading ...
Support Center